Share this to:

Support & Insight for the Autumn of Life

The A4 Study to Prevent Alzheimer’s: Now is the Time


The A4 Study is a cutting-edge trial aimed at preventing Alzheimer’s. The clinical trial is testing healthy adults who are at risk for the dementia. It is the first trial to alert people to their risk in advance.

Read about the research. See Dr. Sperling describe its real potential to create a vaccination that prevents memory loss.

A cutting-edge clinical trial is testing whether early medical intervention in people at risk for Alzheimer’s can slow down progression of disease pathology before symptoms emerge.

Continued below video…

For the first time, people with no Alzheimer’s disease symptoms are being told of their risk status before being asked to join the randomized controlled trial. As part of the overall prevention trial, neurodegenerative ethics experts monitor how learning about their risk of developing Alzheimer’s impacts trial participants.

Alzheimer’s disease afflicts more than 13% of individuals over the age of 65, and remains one of the most feared consequences of aging.

10,000 individuals between the agos of 65 and 85 are needed to find the one thousand participants who will be the perfect fit.

The A4 Trial (Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease Trial) requires that patients enrolled must have one of the pathologies typically seen in Alzheimer’s disease dementia, which will be assessed using a brain PET scan that measures amyloid. Given that studies have shown that about one third of clinically normal older individuals have evidence of amyloid plaque accumulation but may not develop any cognitive symptoms within their lifetime, the patients who are enrolled in the trial based on positive amyloid results may or may not go on to develop Alzheimer’s disease dementia.

The A4 study is a landmark public-private partnership, funded by theNational Institute on Aging/NIHEli Lilly and Company, and several philanthropic organizations. The A4 trial is coordinated by the Alzheimer’s Disease Cooperative Study, located at the University of California, San Diego.

Now is the time.



  1. R. A. Sperling, D. M. Rentz, K. A. Johnson, J. Karlawish, M. Donohue, D. P. Salmon, P. Aisen. The A4 Study: Stopping AD Before Symptoms Begin? Science Translational Medicine, 2014; 6 (228): 228fs13 DOI: 10.1126/scitranslmed.3007941
Notify of

1 Comment
Inline Feedbacks
View all comments
March 2, 2015 2:24 am

what if your grandmother had it,your mom (91) has dementia /alzheimers and daughters are 58 and 61. Why not look a use less than 65 years of age who see the genetic history.

B. Berger

B. Berger

Visit Our Pages On:


This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor


a woman with a stethoscope taking blood pressure of a woman in a chair
6 Tips Reduce Female Stroke Risk
Vascular dementia is a common dementia, often brought on by stroke. Check out strategies to prevent stroke in women.
two blue beach chairs near body of water
400,000 People Show Delaying Retirement Delays Dementia
French researchers conclude delaying retirement can delay dementia in a big way. Learn why.
person wearing hearing aid
Can Hearing Aids Diminish Dementia?
Hearing loss and dementia may be linked, but there is a silver lining here.
Would love your thoughts, please comment.x
News, Treatments, Care Tips

Subscribe To The Weekly Newsletter

videos & articles on Research & Prevention
News to Get at the Truth

Subscribe To Our Weekly Newsletter